Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 04-10-2022
48.71 USD   +1.99%
22/08Intra-Cellular Therapies, Inc. : Goldman Sachs verlaagt advies naar Neutraal
MM
15/08Insider Sell: Intra-Cellulaire Therapieën
MT
11/08Intra-Cellular Therapies, Inc. : Mizuho Securities bevestigt koopadvies
MM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŰnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŰle publicatiesSectornieuws
Nieuws in andere talen op INTRA-CELLULAR THERAPIES, INC.
26/09Insider Sell: Intra-Cellular Therapies
22/08Analyst recommendations: Snowflake, Vipshop, UIta Beauty, VF, Ad..
15/08Insider Sell: Intra-Cellular Therapies
09/08Intra Cellular Therapies : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORP..
09/08Transcript : Intra-Cellular Therapies, Inc., Q2 2022 Earnings Call, Aug 09, 2..
09/08Intra-Cellular Therapies Q2 Net Loss Widens, Revenue Climbs
09/08INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
09/08Intra-cellular : Q2 Earnings Snapshot
09/08Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
09/08Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Cor..
09/08Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q2 Revenue $55.6M
09/08Intra-Cellular Therapies, Inc. Reports Earnings Results for the Second Quarter and Six ..
02/08Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call ..
13/06Intra-cellular Therapies, Inc. : Submission of Matters to a Vote of Security Holders (form..
13/06Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations ..
10/05Sector Update: Health Care Stocks Carried Higher by Surging Biotechs
10/05Sector Update: Health Care Stocks Still Edging Higher This Afternoon
10/05Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises; Shares Rise Tuesday Afternoon
10/05Intra-Cellular Therapies Q1 Loss Expands; Revenue Rises
10/05Transcript : Intra-Cellular Therapies, Inc., Q1 2022 Earnings Call, May 10, 2..
10/05INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
10/05Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $35M
10/05Intra-cellular : Q1 Earnings Snapshot
10/05Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
10/05Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corp..
10/05Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended Mar..
03/05Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call a..
26/04Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA (lu..
25/04Intra-Cellular Therapies Says FDA Approves Two New Dosage Strengths for Treatment of Sc..
25/04Intra Cellular Therapies : Announces FDA Approval of New Dosage Strengths for CAPLYTA« (lu..
25/04Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
25/04Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA« (l..
25/04Intra-Cellular Therapies, Inc. Announces FDA Approval of New Dosage Strengths for CAPLY..
21/04Intra Cellular Therapies : Announces Appointment of E. Rene Salas to Board of Directors - ..
21/04Intra-cellular Therapies, Inc. : Change in Directors or Principal Officers, Financial Stat..
21/04Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
21/04Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors a..
11/04Insider Sell: Intra-Cellular Therapies
05/04Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Confe..
21/03Insider Sell: Intra-Cellular Therapies
06/03Certain Option of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreement End..
06/03Certain Common Stock of Intra-Cellular Therapies, Inc. are subject to a Lock-Up Agreeme..
06/03Certain Restricted Stock Unit of Intra-Cellular Therapies, Inc. are subject to a Lock-U..
01/03Transcript : Intra-Cellular Therapies, Inc., Q4 2021 Earnings Call, Mar 01, 2..
01/03Intra-Cellular Therapies Widens Q4 Net Loss as Revenue Doubles
01/03Intra Cellular Therapies : REPORTS FOURTH QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS AND..
01/03Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
01/03Intra-Cellular Therapies, Inc. Reports Earnings Results for the Fourth Quarter Ended De..
01/03Intra-cellular : Q4 Earnings Snapshot
01/03INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
01/03Intra-Cellular Therapies, Inc. Reports Earnings Results for the Full Year Ended Decembe..
01/03Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q4 Revenue $25.7M
01/03Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results an..
24/02Insider Sell: Intra-Cellular Therapies
22/02Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Co..
10/02Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Co..
12/01Insider Sell: Intra-Cellular Therapies
10/01Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
10/01Transcript : Intra-Cellular Therapies, Inc. Presents at JPMorgan 40th Annual ..
07/01Intra Cellular Therapies : Announces Closing of $460 Million Public Offering Including Ful..
07/01Intra-Cellular Therapies Closes $460 Million Common Stock Offering
07/01Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
07/01Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
05/01Intra Cellular Therapies : Information relating to Item 14 of the Registration Statement o..
05/01Intra Cellular Therapies : Financial Statements - Form 8-K
05/01Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement, Other Events,..
05/01Intra-cellular Therapies, Inc. : Financial Statements and Exhibits (form 8-K)
05/01Intra-Cellular Therapies Prices Common Stock Offering at $42 Per Share
05/01Intra-Cellular Therapies Prices Public Offering of Common Stock
04/01After Hours Watch List Scorecard: LQDA, ITCI, CNM
04/01Health Care Stocks Stumble Through Weak Tuesday Session
04/01Health Care Stocks Retreating Tuesday as Biotechs Sink
04/01Sector Update: Health Care
04/01Health Care Stocks Mixed Pre-Bell Tuesday
04/01Intra-Cellular Therapies Kicks off $400 Million Share Offering -- Stock Slumps in Pre-M..
04/01Intra Cellular Therapies : Announces Proposed Public Offering of Common Stock - Form 8-K
04/01Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
03/01MT Newswires After Hours Watch List: LQDA, ITCI, CNM
03/01Intra-Cellular Therapies Starts Share Offering -- Stock Dives 11% After-Hours
03/01Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
03/01Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
03/01Intra-Cellular Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conferenc..
2021Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement, Financial Sta..
2021Insider Sell: Intra-Cellular Therapies
2021Insider Sell: Intra-Cellular Therapies
2021US Stocks Slide Amid Omicron Fears, Uncertainty Over Biden Spending Plan
2021US Stocks Start Week Lower Amid Omicron Fears, Uncertainty Over Biden Spending Plan
2021Health Care Stocks Down Moderately Amid Market Losses
2021Health Care Stocks Down Less Than Market Monday
2021Top Midday Gainers
2021Intra-Cellular Therapies Drug Receives US FDA Approval for Bipolar Depression Treatment..
2021Intra-Cellular Therapies Says FDA Approved Caplyta to Treat Bipolar Depression, Shares ..
2021Intra-Cellular Therapies Obtains FDA Approval for Bipolar Depression Treatment; Shares ..
2021Intra Cellular Therapies : Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the ..
2021Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
2021Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the..
2021Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the..
2021Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the..
2021Intra-cellular Therapies, Inc. : Other Events, Notice of Delisting or Failure to Satisfy a..
2021Intra-Cellular Therapies, Inc. Announces Demise of Richard Lerner, Member of the Board ..
Volgende evenement op INTRA-CELLULAR THERAPIES, INC.